Board approved audited standalone and consolidated financial results for Q4 and FY ended 31 March 2026, following CIRP withdrawal approved by NCLT.
Company reported standalone net profit of ₹20,469.52 crore for FY26 versus loss of ₹11,027.19 crore in Q4, driven by ₹19,856.78 crore exceptional gain from OTS settlement.
Successfully completed preferential allotment of 277.10 million shares at ₹10 per share, raising ₹277.10 crore to strengthen equity base.
Auditors issued unmodified opinion but emphasized matters regarding impairment provisions, write-offs, and recoverability of significant advances and loans.